In the context of the United Kingdom’s notification on 29 March 2017 of its intention to withdraw from the Union pursuant to Article 50 of the Treaty on European Union (‘TEU’), the other 27 Member States, meeting on 20 November 2017 in the margins of the Council, selected Amsterdam, the Netherlands, as the new seat of the European Medicines Agency (‘the Agency’).
I gcomhthéacs an fhógra a thug an Ríocht Aontaithe an 29 Márta 2017 go bhfuil sé ar intinn aici tarraingt siar ón Aontas de bhun Airteagal 50 den Chonradh ar an Aontas Eorpach (“CAE”), roghnaigh na 27 mBallstát eile, ar theacht le chéile dóibh ar an 20 Samhain 2017 ar imeall na Comhairle, Amstardam na hÍsiltíre mar shuíomh nua na Gníomhaireachta Leigheasra Eorpaí (“an Ghníomhaireacht”).